Verdict94/ 100
Grade A · #1CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
CoreAge Rx vs Gala Health
Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
vs
Verdict86/ 100
Grade B · #7Gala Health
A cheap compounded entry with a real brand-Ozempic path and nationwide coverage — but the $179 is a yearly-subscription rate, and Gala publishes no month-to-month price at all, which is what the verdict now docks it hardest for.
Visit Gala HealthThe verdict
Winner: CoreAge Rx
CoreAge Rx takes it with a higher Verdict Score — 94/100 to 86/100 (grade A vs B). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. Gala Health still earns its place — patients in any state willing to commit to a year up front for a low compounded tirzepatide rate, while keeping a legitimate brand-name option on the table.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
92Real-world results85
92
Real-world results85
97Price honesty87
97
Price honesty87
96Prescriber access88
96
Prescriber access88
88Formulary choice88
88
Formulary choice88
95Cancellation fairness84
95
Cancellation fairness84
93Member support84
93
Member support84
Price, coverage & features
| Metric | CoreAge Rx | Gala Health |
|---|---|---|
| Verdict Score | 94/100 | 86/100 |
| Grade | A | B |
| Semaglutide | $99/mo | Not disclosed |
| Tirzepatide | $149/mo | $179/mo (annual) |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | No | No |
CoreAge Rx
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Gala Health
What we like
- Low compounded entry at $179/mo — on a yearly subscription — with all doses included, so titrating up costs nothing extra
- Available in all 50 states, so access never blocks the sign-up
- Offers a real FDA-approved brand path (Ozempic) alongside the compounded track, which most compounded-only programs cannot
- Adjacent HRT and menopause care for patients who want more than a GLP-1 alone
The caveats
- The $179 requires a yearly subscription — no month-to-month rate is published, and the cheapest term quoted in prose is $199/mo on a 3-month plan
- The $149 'microdose' tier is sub-therapeutic — a longevity protocol, not a cheaper weight-loss dose
- GLP-1 is compounded, not FDA-approved — the standard verification caveat applies
- Brand Ozempic runs $1,299/mo, and the dispensing pharmacy is never named — vet it yourself
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
Patients in any state willing to commit to a year up front for a low compounded tirzepatide rate, while keeping a legitimate brand-name option on the table.
Visit Gala Health Read the full Gala Health review →Keep comparing
Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for Gala Health does the reverse.
Or browse the full comparison hub and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.